Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 13, 2022
Patent Application Number
17714196
Date Filed
April 6, 2022
Patent Citations
Patent Citations Received
Patent Primary Examiner
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ANGPTL3 gene, as well as methods of inhibiting expression of ANGPTL3 and methods of treating subjects having a disorder of lipid metabolism, such as hyperlipidemia or hypertriglyceridemia, using such dsRNA compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
